EQL Pharma AB (publ)

kr 25.95As of Sun 8 Nov 2026, 12:00 UTC
STO:EQLHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 14.96%
Div yield —
ROE 0.43%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.35
PE TTM 731.9
TSR TTM (57.25%)
Mkt cap kr 766.3M
ROIC 1.45%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 28
8.86%
(43.67%)
Hold 1|8|2|11|3
3Q26
4Q26
1Q27
2Q27
Earnings per sharekr
0.43
0.42
0.41
0.44
14.78%
8.34%
10.17%
10.17%
Revenuekr M
88.90
92.09
92.53
94.54
2.56%
6.38%
8.46%
11.19%
Peers (US$77.47M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.166
0.828
0.796
EBIT/Intx
0.077
0.136
0.167
Own earn%
19.78
(36.21)
(32.60)
Sh yield%
16.50
33.55
33.36
Owners
Insiders/Inst%
10.78
56.33
Short interest%
2.45
SBC / revenue%
5.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
6–13
$1 testx
—
Incr. ROIC%
0